Patents by Inventor Calvin E. Collins

Calvin E. Collins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of infectious keratoconjunctivitis in animals
    Patent number: 4219545
    Abstract: The oral administration to animals of riboflavin is an effective therapeutic treatment for keratoconjunctivitis. Suitable riboflavin dosages for this treatment are in the nature of from about 65 milligrams to about 200 milligrams per animal per day. The riboflavin may be orally administered by mixing with ground feed or corn or by incorporation with mineral salt into a salt lick. Additional ingredients with the riboflavin such as antibiotics, vitamin A and other vitamins assist in the treatment. Suitable antibiotics include tetracycline, neomycin, and oxytetracycline.
    Type: Grant
    Filed: March 23, 1979
    Date of Patent: August 26, 1980
    Inventor: Calvin E. Collins